
Customs Pharmaceuticals, a full-service contract development and manufacturing organisation (CDMO), has launched Centrix Pharma Solutions, a new company targeting faster …

VALANX Biotech, a company developing novel technology for site-specific protein conjugation in drug discovery, has appointed Klause Orlinger as Chief …

BioMed X has announced a new collaboration with Novo Nordisk to improve oral delivery of therapeutic peptides – a major …

BioDuro, a contract research, development and manufacturing organisation, has announced a strategic partnership with small molecule design specialist Silicogenix (SGX) …

Portfolio therapeutics company Apollo Therapeutics has announced earlier this week that it will provide capital and expertise to Oxford University’s …

Global manufacturer for the pharmaceutical, biotech and nutraceutical markets, Lonza has announced that it has acquired Synaffix, a biotech company …

Merck has announced that it has invested €35m in biosafety testing at its sites in Glasgow and Stirling, both Scotland. …

New research has pinned a concrete figure on the perennial industry question: how much does it cost to bring a …

A report from the Home Office of the UK Government has revealed that the prevalence of animal testing in the …

Roche’s Genentech unit has signed a deal with Massachusetts-based firm Skyhawk Therapeutics to develop and commercialise small molecules that modulate …
NDA would like to invite you to join Professor Steffen Thirstrup, Director NDA Advisory Board, formerly Division Head at the Danish Medicines …

Researchers at the Wellcome Sanger Institute and Open Targets have been able to identify thousands of genes which play a …

With the technologies reaching exciting levels of maturity and adoption, Matt Fellows investigates how AI and machine learning can be …

H. Lundbeck A/S (CPH: LUN) and Otsuka Pharmaceutical said the US Food and Drug Administration (FDA) have granted Fast Track …
French drugmaker Sanofi (Euronext: SAN) said it will co-develop a Zika vaccine candidate with the US government. No financial details …